| abstract |
The present invention provides methods for inhibiting Fyn kinase, using compounds 5-3-pyridin-2-amine, 6-3-imidazo [1,2-a] pyrazine, 6-3-imidazo [1,2-b] pyridazine , N- (5-imidazo [2,1-b] [1,3,4] thiadiazol-2-yl) -amine, 4-3-1H-pyrazolo [3,4-b] pyridine and N- (3 -imidazo [1,2-b] pyridazin-6-iI) amine and methods of treatment, prevention, inhibition or improvement of diseases and conditions associated with Fyn kinase using such compounds. |